Raleigh Capital Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-93
Closed -$6.89K – 597
2025
Q2
$6.89K Buy
+93
New +$6.47K ﹤0.01% 377
2025
Q1
– Sell
-146
Closed -$11.4K – 750
2024
Q4
$11.4K Sell
146
-52
-26% -$4.42K ﹤0.01% 587
2024
Q3
$18.6K Buy
198
+28
+16% +$2.35K 0.01% 451
2024
Q2
$13.2K Buy
170
+11
+7% +$897 0.01% 517
2024
Q1
$14.5K Buy
159
+100
+169% +$8.32K 0.01% 485
2023
Q4
$4.59K Buy
59
+48
+436% +$3.36K ﹤0.01% 750
2023
Q3
$777 Buy
+11
New +$800 ﹤0.01% 861

Other funds holding GEHC

Raleigh Capital Management's GEHC Position: Q3 2025 in Review

Raleigh Capital Management sold out of GE HealthCare (GEHC) in Q3 2025, closing a stake of 93 shares — an estimated $6.89K sold.

Raleigh Capital Management first reported a position in GEHC in Q3 2023 and held it in 7 quarters. The position peaked at $18.6K in Q3 2024. 1,281 funds tracked by Wall St. Rank hold GEHC as of Q3 2025.

  • Raleigh Capital Management reported no remaining GE HealthCare position as of Q3 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 93 GE HealthCare shares in Q3 2025, an estimated $6.89K.
  • Raleigh Capital Management first reported a position in GE HealthCare in Q3 2023 and held it in 7 quarters.
  • Raleigh Capital Management's GE HealthCare position peaked at $18.6K in Q3 2024.
  • 1,281 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2025.

Based on Raleigh Capital Management's 13F filing for Q3 2025, filed 4 Nov 2025.